utensils and space usage expense of production unit. Major part of cost of sales is raw materials. 2020 vs 201912M 84 68 329 251 Q4/19 Q4/20 2019 2020 29.4% 32.4% -19% -24% 27.4% 32.5% 64.7% 60.9% 2020 vs
and total portfolio and a strong growth of both domestic and overseas subsidiaries. In addition, the Company efficiently managed the selling, general and administrative expense and funding cost. 2
franchise branches. Cost of Sales and Services Item 3rd Quarter (July-September) 2018 2019 THB Mn % (1) THB Mn % (1) Revenue from Sales and Service 736.1 98.0% 759.5 97.2% Franchise Fee Income 15.2 2.0% 22.0
cost of inventories to net realizable value. Related technology business In 2018, the Group has gross profit of Baht 483 million, which is increased by Baht 338 million or 233% compared to the gross
2019 as well as having the enhancing cost control measures. The details of the Company's performance were as follows: 2018 2019 YoY Mio. % Mio. % Mio. % Rental and Service Income 534.1 58.3% 465.9 50.2
, with 0.18 million baht decrease with no significantly transaction changes. 2. Cost of sale , Profit margin For Quarter 1 of the year 2020, the company had cost of sale of 98.36 million bath compare to
million or 7%, mainly due to an increase in cost of real estate sold which varied with an increase in revenue from sales of real estate. Page 3 of 4 IV Expense (Unit: Million Baht) Second quarter 6-month
) Expense Quarter 2/2020 company and its subsidiaries has total expenses of 607.05 Million Baht as 227.63 Million Baht decreased from same period of year 2019 which has total expenses of 834.68 Million Baht
Floor, Silom Road, Suriyawong, Bangrak, Bangkok 10500, Thailand. Tel. 02-634-0225 Fax 02-634-0135 www.interpharma.co.th 3-Month Period Ending March 31st 2020 2019 Change MB % MB % MB % Cost of Sales 35.76
the new iPhone13 in the previous quarter. However, the sales margin grew from +0.9% in 4Q21 to +1.4% in 1Q22 due to an increased sales mix of higher-margin handsets. Cost & Expense In 1Q22, the cost of